The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services
Roots Analysis is pleased to announce the publication of its recent study, titled, “Long-Acting Drug Delivery Market, 2023-2035”
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes
§ An executive summary of the insights captured during our research. It offers a high-level view on the current state of long acting drugs delivery technologies and services market and its likely evolution in the mid-long term.
§ A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery.
§ A detailed assessment of the current technology landscape of long-acting drug delivery technologies.
§ A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery.
§ A technology competitiveness analysis of long-acting drug delivery technologies.
§ A company competitiveness analysis of long-acting drug delivery service providers.
§ Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion).
§ A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
§ A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery.
§ An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018.
§ A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Principle
§ Manipulation of drug release from delivery systems
§ Manipulation of in vivo clearance
§ Strategy
§ Chemical Modification
§ Micro-encapsulation
§ Long-Acting Hydrogels
§ Long-Acting Implants
§ Long-Acting Microneedles
§ Multivesicular Liposomes
§ Nanocrystal Suspensions
§ Protein Fusion
§ Compatible Dosage Form
§ Injectables
§ Implantables
§ Oral Dosage Forms
§ Topical / Transdermal Dosage Forms
§ Vaginal Dosage Forms
§ Other Dosage Forms
§ Type of Molecules Delivered
§ Small Molecules
§ Biologics
§ Other Molecules
§ Type of Material Used
§ Polymer based
§ Non-polymer based
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Middle East and North Africa
Key companies covered in the report
§ Adare Pharma Solutions
§ AMW
§ Bostal Drug Delivery
§ Creative Biolabs
§ ForDoz Pharma
§ Innocore Pharmaceuticals
§ Integral BioSystems
§ LATITUDE Pharmaceuticals
§ Navin Saxena Research and Technology Centre (NSRT)
§ Samyang Biopharm
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html
You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market
Lipid Nanoparticles in Drug Delivery
Bioavailability enhancement services market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
